<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320539">
  <stage>Registered</stage>
  <submitdate>21/09/2010</submitdate>
  <approvaldate>6/10/2010</approvaldate>
  <actrnumber>ACTRN12610000844044</actrnumber>
  <trial_identification>
    <studytitle>Arterial stiffness and renal outcome in kidney transplant patients</studytitle>
    <scientifictitle>Arterial stiffness and renal outcome in kidney transplant patients</scientifictitle>
    <utrn />
    <trialacronym>Arterial stiffness and renal outcome in kidney transplant patients</trialacronym>
    <secondaryid>CRG110600098 (Cochrane Renal Group)</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Renal transplant patients</healthcondition>
    <healthcondition>vascular risk factors</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Kidney disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Cohort study to evaluate vascular risk markers in renal transplant recipients for patient and transplant survival for 5 years
methods: renal resistance index measured by color-coded duplex ultrasound; arterial sffness measured by pulse wave velocity; assymmetric dimethyl arginine measured by chromatography, angiopoetin2 measured by Enzyme-linked immunosorbent assay (ELISA)</interventions>
    <comparator>None</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>graft survival 
(clinical Assessment and renal function tests)</outcome>
      <timepoint>3 and 5 years from baseline</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient survival
( clinical assessment)</outcome>
      <timepoint>3 and 5 years from baseline</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>return to dialysis

(clinical assessement and renal function tests)</outcome>
      <timepoint>3 and 5 years from baseline</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- at least 6 months after kidney transplantation

- stable transplant function

- &gt;= 18 years old

- written informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- cardiac arrhythmies which make a measurement of arterial stiffness and renal resistance index impossible

- transplant artery stenosis of &gt; 50% of diameter

- postrenal obstruction (grade 2 or more)

- significant compression of the tr</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/10/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>PD Dr. Ute Eisenberger</primarysponsorname>
    <primarysponsoraddress>University Hospital Bern
Dep. of Nephrology and Hypertension
Freiburgstr. 10
3010 Bern
Switzerland</primarysponsoraddress>
    <primarysponsorcountry>Switzerland</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>University Hospital Bern</fundingname>
      <fundingaddress>Freiburgstrasse 
3010 Bern
Switzerland</fundingaddress>
      <fundingcountry>Switzerland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication>Bergmann I, Boeger RH, Marti E, Schwedthelm, Frey FJ, Eisenberger U.  Renal Resistance Index in Renal Allograft Recipients: A Role for Asymmetric Dimethylarginine.
Am J Kidney Dis. 2009, 54(2): 327-33</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>PD Dr, Ute, Eisenberger</name>
      <address>registrar, Nephrology and Hypertension, University Hospital Inselspital, Freiburgstrasse 10, CH-3010 Bern, Switzerland</address>
      <phone>+41 31 6323144</phone>
      <fax />
      <email>ute.eisenberger@insel.ch</email>
      <country>Switzerland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>PD Dr, Ute, Eisenberger</name>
      <address>senior registrar, Nephrology and Hypertension, University Hospital Inselspital, Freiburgstrasse 10, CH-3010 Bern, Switzerland</address>
      <phone>+41 31 6323144</phone>
      <fax />
      <email>ute.eisenberger@insel.ch</email>
      <country>Switzerland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>